- Published on
Diagnostics Tests: Hypersegmented Neutrophils
Overview
A hypersegmented neutrophil is a neutrophil with an abnormally high number of nuclear lobes. Normal neutrophils average about 3–4 lobes, but when the average exceeds 4 lobes, or when 5% of cells have ≥5 lobes, or when even a single 6-lobed neutrophil is present, the finding is considered hypersegmentation. This morphological change is a classic hematologic clue and serves as a defining feature of megaloblastic anemia.
Associated Diseases
Hypersegmented neutrophils are most commonly seen in:
These deficiencies impair DNA synthesis, leading to delayed nuclear maturation in hematopoietic cells. The result is macrocytosis, ineffective erythropoiesis, and the hallmark hypersegmented neutrophils seen on peripheral blood smear. These findings may accompany clinical features like glossitis, anemia, and—in B12 deficiency—neurologic symptoms.
Most Accurate Diagnostic Tests
To confirm megaloblastic anemia and determine its cause, the following tests are most accurate:
Therapy
Treatment depends on the underlying deficiency:
Overview
A hypersegmented neutrophil is a neutrophil with an abnormally high number of nuclear lobes. Normal neutrophils average about 3–4 lobes, but when the average exceeds 4 lobes, or when 5% of cells have ≥5 lobes, or when even a single 6-lobed neutrophil is present, the finding is considered hypersegmentation. This morphological change is a classic hematologic clue and serves as a defining feature of megaloblastic anemia.
Associated Diseases
Hypersegmented neutrophils are most commonly seen in:
- Vitamin B12 deficiency
- Folate deficiency
These deficiencies impair DNA synthesis, leading to delayed nuclear maturation in hematopoietic cells. The result is macrocytosis, ineffective erythropoiesis, and the hallmark hypersegmented neutrophils seen on peripheral blood smear. These findings may accompany clinical features like glossitis, anemia, and—in B12 deficiency—neurologic symptoms.
Most Accurate Diagnostic Tests
To confirm megaloblastic anemia and determine its cause, the following tests are most accurate:
- Serum vitamin B12 and folate levels – first-line and most direct assessment.
- Methylmalonic acid (MMA) – elevated in B12 deficiency only, not folate deficiency, making it helpful for distinguishing between the two.
- Homocysteine levels – elevated in both B12 and folate deficiency (helps support the diagnosis, but not specific).
- Anti–intrinsic factor antibodies and antiparietal cell antibodies – used to identify pernicious anemia, the classic autoimmune cause of B12 deficiency.
Therapy
Treatment depends on the underlying deficiency:
- Vitamin B12 deficiency:
- Replacement with intramuscular B12 injections for severe deficiency or malabsorption
- Oral B12 for mild cases or dietary deficiency
- Lifelong therapy is required for pernicious anemia
- Folate deficiency:
- Oral folic acid supplementation
- Dietary improvement
- Important note: Never treat with folate alone if B12 deficiency is possible, as folate can correct the anemia while allowing neurologic damage from B12 deficiency to persist or worsen.
- Published on
Diagnostic Tests: Hairy Cell Leukemia (Blood Smear Findings)
Overview — What the Blood Smear Shows
The blood smear displays lymphoid cells with characteristic cytoplasmic projections, known as “hairy cells.” These projections give the cells a fuzzy or “hairy” appearance, which is the classic morphologic hallmark of hairy cell leukemia (HCL). This is a rare, chronic B-cell lymphoproliferative disorder.
Clinical Scenario — When to Suspect and Answer Hairy Cell Leukemia
Hairy cell leukemia should be strongly suspected when the clinical presentation includes:
This combination—middle-aged patient, massive splenomegaly, pancytopenia, and characteristic smear findings—points to hairy cell leukemia.
Most Accurate Diagnostic Test
The most accurate test for confirming hairy cell leukemia is:
Tartrate-Resistant Acid Phosphatase (TRAP) positivity
(Modern practice also uses flow cytometry markers such as CD11c, CD25, CD103, and detection of BRAF V600E mutation, but TRAP is the classic board-test answer.)
If you’d like, I can also create a rapid diagnostic table comparing hairy cell leukemia with CLL, AML, and other pancytopenia causes.
Clinical Scenario — When to Suspect and Answer Hairy Cell Leukemia
Hairy cell leukemia should be strongly suspected when the clinical presentation includes:
This combination—middle-aged patient, massive splenomegaly, pancytopenia, and characteristic smear findings—points to hairy cell leukemia.
Overview — What the Blood Smear Shows
The blood smear displays lymphoid cells with characteristic cytoplasmic projections, known as “hairy cells.” These projections give the cells a fuzzy or “hairy” appearance, which is the classic morphologic hallmark of hairy cell leukemia (HCL). This is a rare, chronic B-cell lymphoproliferative disorder.
Clinical Scenario — When to Suspect and Answer Hairy Cell Leukemia
Hairy cell leukemia should be strongly suspected when the clinical presentation includes:
- A middle-aged man (most common demographic)
- Gradual onset of fatigue, weakness, or recurrent infections
- Massive splenomegaly, often the dominant physical finding
- Hepatomegaly (present in about 50% of patients)
- Pancytopenia, which is the hallmark laboratory abnormality
- Particularly monocytopenia
- Bone marrow often becomes fibrotic and difficult to aspirate (“dry tap”)
This combination—middle-aged patient, massive splenomegaly, pancytopenia, and characteristic smear findings—points to hairy cell leukemia.
Most Accurate Diagnostic Test
The most accurate test for confirming hairy cell leukemia is:
Tartrate-Resistant Acid Phosphatase (TRAP) positivity
- Performed on a bone marrow biopsy
- Hairy cells show strong acid phosphatase activity that remains positive even in the presence of tartrate, distinguishing them from other leukemic cells.
(Modern practice also uses flow cytometry markers such as CD11c, CD25, CD103, and detection of BRAF V600E mutation, but TRAP is the classic board-test answer.)
If you’d like, I can also create a rapid diagnostic table comparing hairy cell leukemia with CLL, AML, and other pancytopenia causes.
Clinical Scenario — When to Suspect and Answer Hairy Cell Leukemia
Hairy cell leukemia should be strongly suspected when the clinical presentation includes:
- A middle-aged man (most common demographic)
- Gradual onset of fatigue, weakness, or recurrent infections
- Massive splenomegaly, often the dominant physical finding
- Hepatomegaly (present in about 50% of patients)
- Pancytopenia, which is the hallmark laboratory abnormality
- Particularly monocytopenia
- Bone marrow often becomes fibrotic and difficult to aspirate (“dry tap”)
This combination—middle-aged patient, massive splenomegaly, pancytopenia, and characteristic smear findings—points to hairy cell leukemia.
- Published on
Diagnostic Tests: Peripheral Smear Findings in G6PD Deficiency
Overview — What the Peripheral Smear Shows
This peripheral smear demonstrates Heinz bodies, which are inclusions formed by precipitated, oxidized hemoglobin inside red blood cells. These occur when RBCs are exposed to oxidative stress in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
G6PD deficiency is an X-linked recessive condition and is particularly common in African-American males (10–15%).
Clinical Scenario — When This Is the Correct Answer
You should suspect G6PD deficiency when the presentation describes a previously healthy male who suddenly develops signs of acute intravascular hemolysis after oxidative stress. Key features include:
Common triggers of oxidative stress include:
When a question stem includes these triggers plus acute hemolysis and the smear shows characteristic RBC inclusions, G6PD deficiency is the diagnosis.
Other Cells Characteristic of G6PD Deficiency
Once Heinz bodies form, the spleen attempts to remove them. This “pitting” process produces:
Bite cells (degmacytes)
Definitive Diagnostic Test
The definitive test for confirming G6PD deficiency is:
Measurement of G6PD enzyme level
Important caveat:
You must wait approximately 2 months after the hemolytic episode to test.
Immediately after hemolysis, the older, most deficient red cells have already been destroyed. The remaining population consists of young reticulocytes with relatively higher G6PD activity, which can give a false-normal result.
If you’d like, I can also create a comparison chart of G6PD deficiency vs. other hemolytic anemias (like autoimmune hemolysis or sickle cell), or provide a rapid-review summary for exams.
Overview — What the Peripheral Smear Shows
This peripheral smear demonstrates Heinz bodies, which are inclusions formed by precipitated, oxidized hemoglobin inside red blood cells. These occur when RBCs are exposed to oxidative stress in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
G6PD deficiency is an X-linked recessive condition and is particularly common in African-American males (10–15%).
Clinical Scenario — When This Is the Correct Answer
You should suspect G6PD deficiency when the presentation describes a previously healthy male who suddenly develops signs of acute intravascular hemolysis after oxidative stress. Key features include:
- Weakness and fatigue
- Tachycardia
- Jaundice
- Dark urine (hemoglobinuria)
- Sudden drop in hemoglobin
Common triggers of oxidative stress include:
- Infections (most common cause)
- Drugs, including:
- Sulfa drugs
- Primaquine
- Dapsone
- Quinidine
- Nitrofurantoin
- Fava beans (favism)
When a question stem includes these triggers plus acute hemolysis and the smear shows characteristic RBC inclusions, G6PD deficiency is the diagnosis.
Other Cells Characteristic of G6PD Deficiency
Once Heinz bodies form, the spleen attempts to remove them. This “pitting” process produces:
Bite cells (degmacytes)
- RBCs appear as though a bite has been taken out of them.
- These cells are classic for G6PD deficiency and often accompany Heinz body formation.
Definitive Diagnostic Test
The definitive test for confirming G6PD deficiency is:
Measurement of G6PD enzyme level
Important caveat:
You must wait approximately 2 months after the hemolytic episode to test.
Immediately after hemolysis, the older, most deficient red cells have already been destroyed. The remaining population consists of young reticulocytes with relatively higher G6PD activity, which can give a false-normal result.
If you’d like, I can also create a comparison chart of G6PD deficiency vs. other hemolytic anemias (like autoimmune hemolysis or sickle cell), or provide a rapid-review summary for exams.
- Published on
Click here to start customizing
- Published on
Diagnostic Tests: Auer Rods
Overview — What This Is
The structure shown is an Auer rod, which is an eosinophilic, needle-shaped cytoplasmic inclusion found within myeloblasts or promyelocytes. These inclusions are composed of abnormal azurophilic granules and represent crystalline aggregates of myeloperoxidase. Their presence indicates a malignant proliferation of myeloid precursors.
Disease Associated With Auer Rods
Auer rods are pathognomonic for acute myelogenous leukemia (AML).
They may appear in several AML subtypes, but are especially prominent in:
• Acute Promyelocytic Leukemia (APL, M3) — often showing bundles of Auer rods (“faggot cells”), which is a high-yield test clue.
Their presence confirms the myeloid origin of the malignant blasts
When This Is the Correct Answer
You should answer Auer rods / AML when the question presents a patient with:
• Pancytopenia (fatigue, infections, bleeding)
• Peripheral smear showing blasts
• >20% blasts on bone marrow biopsy, meeting diagnostic criteria for acute leukemia
• Systemic symptoms such as fatigue, fever, infections, bruising, or bleeding
Additional diagnostic support includes:
• Myeloperoxidase (MPO) positivity on histochemical staining
• Expression of myeloid markers: CD13, CD33, CD117
• Presence of Auer rods confirms AML over ALL or other hematologic malignancies
In APL (t(15;17)), Auer rods are particularly dense and clinically important because the disease is associated with DIC, and treatment requires all-trans retinoic acid (ATRA).
Overview — What This Is
The structure shown is an Auer rod, which is an eosinophilic, needle-shaped cytoplasmic inclusion found within myeloblasts or promyelocytes. These inclusions are composed of abnormal azurophilic granules and represent crystalline aggregates of myeloperoxidase. Their presence indicates a malignant proliferation of myeloid precursors.
Disease Associated With Auer Rods
Auer rods are pathognomonic for acute myelogenous leukemia (AML).
They may appear in several AML subtypes, but are especially prominent in:
• Acute Promyelocytic Leukemia (APL, M3) — often showing bundles of Auer rods (“faggot cells”), which is a high-yield test clue.
Their presence confirms the myeloid origin of the malignant blasts
When This Is the Correct Answer
You should answer Auer rods / AML when the question presents a patient with:
• Pancytopenia (fatigue, infections, bleeding)
• Peripheral smear showing blasts
• >20% blasts on bone marrow biopsy, meeting diagnostic criteria for acute leukemia
• Systemic symptoms such as fatigue, fever, infections, bruising, or bleeding
Additional diagnostic support includes:
• Myeloperoxidase (MPO) positivity on histochemical staining
• Expression of myeloid markers: CD13, CD33, CD117
• Presence of Auer rods confirms AML over ALL or other hematologic malignancies
In APL (t(15;17)), Auer rods are particularly dense and clinically important because the disease is associated with DIC, and treatment requires all-trans retinoic acid (ATRA).
- Published on
Diagnostic Tests: Fragmented Red Blood Cells (Schistocytes)
Overview — What This Is
The smear shows fragmented red blood cells, also referred to as schistocytes or helmet cells. These irregularly shaped RBC fragments form when erythrocytes are mechanically sheared within the circulation. Their presence is a hallmark of intravascular hemolysis and defines microangiopathic hemolytic anemia (MAHA).
Diseases Associated With Schistocytes
Fragmented RBCs occur in conditions where red cells are destroyed while passing through areas of fibrin deposition, turbulence, or mechanical injury. Major associated disorders include:
- Thrombotic Thrombocytopenic Purpura (TTP)
- Hemolytic Uremic Syndrome (HUS)
- Disseminated Intravascular Coagulation (DIC)
- Major blood group incompatibility (e.g., ABO mismatch)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Mechanical destruction from:
- Artificial heart valves
- Mechanical circulatory support devices (e.g., LVADs)
- Snake bites (due to hemotoxic venom effects)
These conditions share a common mechanism—red cell fragmentation within the vascular system.
Associated Laboratory Abnormalities
Because schistocytes signify intravascular hemolysis, several classic lab abnormalities accompany their presence:
- Elevated LDH — released from destroyed RBCs
- Elevated indirect (unconjugated) bilirubin — from heme breakdown
- Elevated reticulocyte count — bone marrow compensation
- Decreased haptoglobin — binds free hemoglobin, becomes depleted in intravascular hemolysis
- Published on
Diagnostic Tests: Target Cells
Overview — What These Are?
The cells shown are target cells (codocytes). Target cells have a characteristic “bull’s-eye” appearance caused by an excess of cell membrane relative to cell volume. This altered surface-area–to–volume ratio creates a central area of hemoglobin surrounded by a pale ring and then an outer ring of hemoglobin.
Most Accurate Diagnostic Test
The most accurate diagnostic test when evaluating conditions associated with target cells is:
Hemoglobin Electrophoresis
This test helps identify hemoglobinopathies such as:
- Sickle cell disease
- Hemoglobin C disease
- Thalassemia
Electrophoresis will distinguish between different abnormal hemoglobins and determine specific genetic variants.
Associated Diseases
Target cells may appear in several hematologic and systemic conditions, including:
- Hemoglobinopathies
- Hemoglobin C disease (most strongly associated)
- Sickle cell disease (HbSS)
- Thalassemias (α and β)
- Liver disease
Due to increased membrane lipids, resulting in excess surface area. - Iron deficiency anemia
Though less classic, target cells may be seen in severe cases.
Do Target Cells Have a Shorter Survival?
Despite their abnormal morphology, target cells do NOT have a shorter survival than normal red blood cells.
They are structurally abnormal but not inherently more fragile, unlike spherocytes or sickled cells.
- Published on
Diagnostic Tests: Sickled Cells
Overview — What This Is
The image shows sickled red blood cells, which are elongated, crescent-shaped RBCs formed due to polymerization of abnormal hemoglobin (HbS). Sickled cells are rigid, fragile, and prone to causing vaso-occlusion and hemolysis.
Diseases Associated With Sickled Cells
Sickled cells are seen only in:
Sickle Cell Disease (HbSS — Homozygous)
Important distinction:
Most Accurate Diagnostic Test
The most accurate test for diagnosing sickle cell disease is:
Hemoglobin Electrophoresis
This test identifies and quantifies hemoglobin variants and will show:
Electrophoresis provides definitive confirmation and distinguishes SS from AS and other hemoglobinopathies.
Overview — What This Is
The image shows sickled red blood cells, which are elongated, crescent-shaped RBCs formed due to polymerization of abnormal hemoglobin (HbS). Sickled cells are rigid, fragile, and prone to causing vaso-occlusion and hemolysis.
Diseases Associated With Sickled Cells
Sickled cells are seen only in:
Sickle Cell Disease (HbSS — Homozygous)
- Patients with homozygous hemoglobin S (SS) produce sickled cells, especially during episodes of dehydration, acidosis, hypoxia, or infection.
- These patients exhibit hemolytic anemia, vaso-occlusive crises, acute chest syndrome, splenic infarction, priapism, and other complications.
Important distinction:
- Sickle Cell Trait (AS — Heterozygous) does not produce sickled cells on a routine peripheral smear.
Individuals are generally hematologically normal, though they may sickle under extreme conditions (e.g., severe hypoxia).
Most Accurate Diagnostic Test
The most accurate test for diagnosing sickle cell disease is:
Hemoglobin Electrophoresis
This test identifies and quantifies hemoglobin variants and will show:
- HbS predominates in sickle cell disease (SS)
- A mixture of HbA and HbS in sickle cell trait (AS)
Electrophoresis provides definitive confirmation and distinguishes SS from AS and other hemoglobinopathies.
- Published on
Diagnostic Tests: Spherocytes on Peripheral Smear
Overview — What These Are
The peripheral smear shows spherocytes, which are small, dense red blood cells lacking the normal central pallor. Their spherical shape results from loss of membrane surface area, making them less deformable and more prone to destruction, especially in the spleen. Spherocytes are a hallmark of hereditary spherocytosis, but can also appear in immune hemolysis.
Most Accurate Diagnostic Test
The most accurate diagnostic test for hereditary spherocytosis is the osmotic fragility test.
This test demonstrates that spherocytes lyse more easily than normal RBCs when placed in hypotonic solutions due to their decreased membrane surface area.
(Note: An elevated MCHC is supportive but not the most accurate test.)
Genetic Defect
Hereditary spherocytosis is caused by defects in red blood cell membrane proteins, most commonly involving:
Other possible but less common defects include band 3 and protein 4.2, but ankyrin/spectrin is the classic board answer.
When to Choose This Diagnosis/Test
You should think of hereditary spherocytosis—and choose osmotic fragility as the test—when the case involves:
Overview — What These Are
The peripheral smear shows spherocytes, which are small, dense red blood cells lacking the normal central pallor. Their spherical shape results from loss of membrane surface area, making them less deformable and more prone to destruction, especially in the spleen. Spherocytes are a hallmark of hereditary spherocytosis, but can also appear in immune hemolysis.
Most Accurate Diagnostic Test
The most accurate diagnostic test for hereditary spherocytosis is the osmotic fragility test.
This test demonstrates that spherocytes lyse more easily than normal RBCs when placed in hypotonic solutions due to their decreased membrane surface area.
(Note: An elevated MCHC is supportive but not the most accurate test.)
Genetic Defect
Hereditary spherocytosis is caused by defects in red blood cell membrane proteins, most commonly involving:
- Ankyrin gene mutation → leading to
- Spectrin deficiency → which
- Produces membrane instability and premature RBC destruction (extravascular hemolysis)
Other possible but less common defects include band 3 and protein 4.2, but ankyrin/spectrin is the classic board answer.
When to Choose This Diagnosis/Test
You should think of hereditary spherocytosis—and choose osmotic fragility as the test—when the case involves:
- Recurrent hemolysis
- Splenomegaly (often marked)
- Family history of anemia (autosomal dominant pattern in most cases)
- Increased MCHC on CBC (a high-yield clue)
- Spherocytes on peripheral smear
- Signs of hemolysis: jaundice, increased reticulocytes, gallstones (bilirubin stones)
- Published on
Diagnostic Tests: Teardrop Cells
Overview — What the Peripheral Smear Shows
The smear demonstrates teardrop cells (also called dacrocytes). These red blood cells appear stretched into a teardrop shape, a sign that they were physically distorted during their passage out of a diseased bone marrow.
Diagnostic Significance — When This Is the Answer
When teardrop cells are shown or described in a question stem, the correct diagnostic answer is:
Infiltrative Bone Marrow Disease
The most classic and high-yield association is:
- Myelofibrosis (primary or secondary)
Additional supporting clues may include:
- Pancytopenia
- Massive splenomegaly
- Weight loss, fatigue, night sweats
- Leukoerythroblastic smear (nucleated RBCs + left-shifted myeloid cells)
Bone marrow biopsy in myelofibrosis will reveal reticulin or collagen fibrosis, often making aspiration difficult (“dry tap”).
The diagnosis is chosen after excluding other causes of massive splenomegaly, such as hairy cell leukemia.
